新华制药：2025年年度归属于上市公司股东的净利润是289888855.00元

Group 1 - The core viewpoint of the article is that Xinhua Pharmaceutical reported its 2025 annual results, showing a revenue increase but a significant decline in net profit [1] Group 2 - The company achieved an operating revenue of 8,754,721,987.78 yuan for the year 2025, representing a year-on-year growth of 3.41% [1] - The net profit attributable to shareholders of the listed company was 289,888,855.00 yuan, reflecting a year-on-year decrease of 38.32% [1]